Back to Agenda
Career Planning and Limitations for Mid- to Upper-Level Project Managers
Session Chair(s)
Mark Kryah, PMP
Executive Director, Program Team Leader, Program and Portfolio Management, Ultragenyx, United States
If you have been managing R&D drug development projects for several years, what options do you have for further advancement or to continue to develop depth and expertise? If you feel that you have reached a limit or have plateaued, this forum will provide a variety of perspectives to consider as you evaluate what is next in your career.
Learning Objective : Discuss options to consider when evaluating a career path in R&D project management; Identify one or two tangible action steps in decision-making regarding continuing a career in R&D project management.
Speaker(s)
Michele C. Livesey, MBA
Drug Development Strategy and Execution Consultant, Livesey Consulting, United States
Panelist
Tina Rarick, MBA
President, Angus Bio Consulting, LLC, United States
Panelist
Ben Quartley, PHD
, Labcorp Drug Development, United States
Panelist
Have an account?